ReviewJournal of gastrointestinal oncology2017
Shifting paradigm of developing biologics for the treatment of pancreatic adenocarcinoma.
Ying Zeng et al.PubMed ↗Full text ↗Publisher ↗
No numbers read from the abstract.
3 papers cite it
this papercites it